The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Share News (MPH)

  • There is currently no data for MPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

Mon, 28th Sep 2020 15:53

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

SSE PLC - energy firm - Non-Executive Director Crawford Gilles to step down with effect on Wednesday after five years in the role since 2015. SSE's board to compromise of chair, three executive directors and seven non-executive directors.

----------

Tracsis PLC - traffic data & transportation services - Appoints Andrew Kelly as chief financial officer with effect on February 1, 2021. Will replace Max Cawthra, who is stepping down from role after 10 years since 2011. Kelly is currently vice president of Finance & IT at Vitec Production Solutions, a division of photography & video products maker Vitec Group PLC.

----------

Bank of Cyprus Holdings PLC - banking - First Deputy Chief Executive Officer Chris Patsalides to step down with effect on October 31, after a 25-year tenure with the group. In addition, has appointed Constantine Iordanou as non-executive director and Executive Director of Finance Eliza Livadiotou to board as executive member. Both appointments require approval from European Central Bank.

----------

ULS Technology PLC - Oxfordshire-based conveyancing software provider - Chief Executive Officer Steve Goodall has stepped down from role with immediate effect to pursue other interests, after three years since 2017. Following an extensive search, the group has found a successor with extensive performance, but has not disclosed who the successor is.

----------

Henderson European Focus Trust PLC - investment trust - Appoints Senior Independent Director Vicky Hastings as interim chair, following the stepping down of Chair Robert Jeens with effect on Friday last week, for personal reasons, after ten months in the role since December 2019.

----------

Ovoca Bio PLC - Women's health-focused biopharmaceutical company - Appoints Chief Executive Officer Kirill Golovanov as interim chair with immediate effect, following the death of Executive Chair Mikhail Mogutov on Thursday last week, after 12 years in the role.

----------

Vectura Group PLC - London-based drug delivery products firm - Non-Executive Director Anne Whitaker to step down with effect on Wednesday, due to potential conflicts that could arise in the future, from her role as chief executive officer at Aerami Therapeutics, which specialises in the treatment of severe respiratory and chronic diseases.

----------

Mereo Biopharma Group PLC - London-based clinical-stage biopharmaceutical company focused on oncology and rare diseases - Appoints Brian Schwartz and Jeremy Bender as non-executive directors with effect on October 1. In addition, Non-Executive Director Paul Blackburn to step down after five years since 2015.

----------

British Smaller Companies VCT2 PLC - UK-focused venture capital trust - Appoints Barbara Anderson with effect on October 1. Also announced the resignation of Robert Pettigrew with effect at the end of 2020 after 20 years in the role.

----------

Blue Prism Group PLC - Warrington, England-based robotic process automation - Appoints Rachel Mooney as non-executive director with immediate effect.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
16 Jun 2020 13:02

Mereo BioPharma's Loss Stretches In 2019 But Pleased With Progress

Mereo BioPharma's Loss Stretches In 2019 But Pleased With Progress

Read more
4 Jun 2020 16:47

Mereo Shares Surge As It Completes USD70 Million US Fundraise

Mereo Shares Surge As It Completes USD70 Million US Fundraise

Read more
30 Mar 2020 16:22

EXECUTIVE CHANGE SUMMARY: Medica Poaches CFO From Mereo BioPharma

EXECUTIVE CHANGE SUMMARY: Medica Poaches CFO From Mereo BioPharma

Read more
27 Mar 2020 18:43

Mereo BioPharma Expects No Setrusumab Trial Delays Despite Covid-19

Mereo BioPharma Expects No Setrusumab Trial Delays Despite Covid-19

Read more
28 Feb 2020 16:01

Mereo BioPharma Says US Regulator Meeting For Setrusumab "Successful"

Mereo BioPharma Says US Regulator Meeting For Setrusumab "Successful"

Read more
19 Feb 2020 11:37

Mereo BioPharma Secures USD3 Million Investment From Unnamed US Firm

Mereo BioPharma Secures USD3 Million Investment From Unnamed US Firm

Read more
19 Feb 2020 07:38

Mereo BioPharma enters securities agreement with institutional investor

(Sharecast News) - Mereo BioPharma Group has entered into a securities purchase agreement with a new US-based institutional healthcare investor, it announced on Wednesday.

Read more
10 Feb 2020 13:05

Mereo Secures Novartis Fundraising Amid More Backing From US Investors

Mereo Secures Novartis Fundraising Amid More Backing From US Investors

Read more
14 Jan 2020 13:06

Mereo BioPharma Reports Additional Positive Data From Setrusumab Study

Mereo BioPharma Reports Additional Positive Data From Setrusumab Study

Read more
13 Jan 2020 12:24

Mereo BioPharma Could Net USD300 Million From Navicixizumab Deal

Mereo BioPharma Could Net USD300 Million From Navicixizumab Deal

Read more
18 Dec 2019 19:08

Woodford Transfers Series Of Holdings To New Manager Schroders

Woodford Transfers Series Of Holdings To New Manager Schroders

Read more
11 Nov 2019 13:44

Mereo Gets Positive Setrusumab Trial Results; Plans Pediatric Studies

Mereo Gets Positive Setrusumab Trial Results; Plans Pediatric Studies

Read more
5 Nov 2019 15:13

PRESS: Consortium Circles Healthcare Assets Of Fund Manager Woodford

PRESS: Consortium Circles Healthcare Assets Of Fund Manager Woodford

Read more
14 Oct 2019 13:42

DIRECTOR DEALINGS: Mereo BioPharma Chair Buys GBP15,000 In Shares

DIRECTOR DEALINGS: Mereo BioPharma Chair Buys GBP15,000 In Shares

Read more
7 Oct 2019 14:59

Mereo BioPharma Drug Navicixizumab Gets Fast Track Designation In US

Mereo BioPharma Drug Navicixizumab Gets Fast Track Designation In US

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.